Market News
March 29, 2018 / 12:02 PM / a year ago

BRIEF-Armo Biosciences Enrolls Patient In The Cypress 2 Trial Evaluating AM0010

1 Min Read

March 29 (Reuters) - Armo Biosciences Inc:

* ARMO BIOSCIENCES ENROLLS FIRST PATIENT IN THE CYPRESS 2 TRIAL EVALUATING AM0010 IN NON-SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below